Ann: Immutep receives A$1.9M from French R&D tax cash rebate, page-2

Coupla million out of the blue, novartis starting PH2 should trigger close 

to double digit milestone injection, it seems GSK doing a de facto PH2 on

colitis and psoriasis, who knows with them?.....Marc Voight, popping up

at the opening of an envelop with positive input....There is a confidence 

exuding from the company that is slowly drifting into the market......

Top 20 hold 50%, forget about a takeover in my mind unless fair value

plus potential is factored, at this stage the potential is not quantiable

in my book......